l 778,123 has been researched along with ggti 298 in 1 studies
| Studies (l 778,123) | Trials (l 778,123) | Recent Studies (post-2010) (l 778,123) | Studies (ggti 298) | Trials (ggti 298) | Recent Studies (post-2010) (ggti 298) |
|---|---|---|---|---|---|
| 15 | 0 | 5 | 71 | 0 | 17 |
| Protein | Taxonomy | l 778,123 (IC50) | ggti 298 (IC50) |
|---|---|---|---|
| Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Homo sapiens (human) | 0.054 | |
| Geranylgeranyl transferase type-1 subunit beta | Homo sapiens (human) | 0.054 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, IM | 1 |
1 review(s) available for l 778,123 and ggti 298
| Article | Year |
|---|---|
Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy?
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Design; Farnesyltranstransferase; Genes, ras; Humans; Neoplasms | 2004 |